⌘K

Login Start Free

Home/Filings/4/0001181431-13-034210

4//SEC Filing

RXi Pharmaceuticals Corp 4

Accession 0001181431-13-034210

$PHIOCIK 0001533040operating

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:07 PM ET

Size

5.2 KB

Accession

0001181431-13-034210

Insider Transaction Report

Form 4

Period: 2013-06-07

RXi Pharmaceuticals CorpRXII

Chief Development Officer

Transactions

Award
Stock Option (right to buy)
2013-06-07+2,000,000→ 2,000,000 total
Exercise: $0.20Exp: 2023-06-07→ Common Stock (2,000,000 underlying)

Footnotes (1)

[F1]The award will vest in monthly installments over four years beginning on the first monthly anniversary of the grant date.

Documents

1 file

4
rrd383085.xmlPrimary
FORM 4

Issuer

RXi Pharmaceuticals Corp

CIK 0001533040

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001533040

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 5:07 PM ET
Size: 5.2 KB

View on SEC.gov